Iovance Biotherapeutics Inc. buy Robert W. Baird
Start price
28.02.25
/
50%
€3.77
Target price
28.02.26
€19.21
Performance (%)
-40.83%
Price
03.02.26
€2.23
Summary
This prediction is currently active. Massive losses of -40.83% have been the result for the BUY prediction by Robert_W__Baird. This prediction currently runs until 28.02.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -9.846% | -9.846% |
| iShares Core DAX® | -0.559% | 0.738% |
| iShares Nasdaq 100 | -0.566% | -0.324% |
| iShares Nikkei 225® | 1.073% | 5.624% |
| iShares S&P 500 | 0.868% | 0.030% |
Comments by Robert_W__Baird for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Robert W. Baird from $24.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for IOVA provided by MarketBeat